- Lead. Intel announced a $15 billion common stock offering on August 10 — its first public share sale since the company’s initial public offering in 1971 — as it moves to fund an AI-driven manufacturing expansion.
- Fact. The offering, with a $2.25 billion underwriter option taking the potential total to $17.25 billion, is earmarked for AI chip production, purpose-built silicon, advanced packaging and external wafer services; Intel shares fell roughly 3% pre-market on dilution concerns, having nearly tripled this year to $101.65.
- Stake. The raise signals management’s conviction that the AI infrastructure cycle justifies diluting existing shareholders — and that Intel’s foundry pivot, supported by a 10% US government equity stake, is entering a capital-intensive scaling phase.
Intel Corp. announced the proposed $15 billion common stock offering on August 10, according to the company’s news room and coverage from Bloomberg, CNBC and Digitimes. JPMorgan Securities, Goldman Sachs, Morgan Stanley and Citigroup Global Markets are acting as joint book-running managers. The underwriters hold a 30-day option to purchase up to an additional $2.25 billion of shares, bringing the maximum total to $17.25 billion if exercised in full.
Why Now, and Why Equity
Intel’s choice of equity over debt reflects the scale of capital expenditure requirements in advanced semiconductor manufacturing. The company has been executing a foundry-first strategic orientation — building chips for external customers in addition to its own product lines — and the economics of constructing and equipping leading-edge fabs require multi-billion-dollar commitments over multi-year timelines.
Intel’s stock has nearly tripled in 2026 to reach $101.65, a recovery from years of share price weakness that coincided with the company’s loss of manufacturing leadership to TSMC. The rally reflects the US government’s decision to take a 10% equity stake aimed at bolstering domestic chip capacity, combined with Intel’s 59% AI revenue jump reported in its most recent quarterly earnings. Raising $15 billion at or near the current share price locks in capital at a significantly improved valuation relative to where Intel traded eighteen months ago.
What the Money Funds
Intel described the use of proceeds in broad terms: general corporate purposes including AI chip manufacturing, purpose-built silicon, advanced packaging and external wafer production capacity. The last category — producing chips on contract for other companies — is the clearest signal of where Intel’s management sees the next growth opportunity. An earlier €5 billion commitment to Intel’s Ireland fabrication facility extended capacity in Europe; Monday’s US equity raise provides the balance-sheet room to commission additional capacity globally without equivalent levels of debt.
The question for investors is whether Intel’s foundry business — still in its early stages as a contracted chipmaker — can attract and retain customers of sufficient scale to justify the capital commitment. As of August 10 the shares were trading roughly 3% lower pre-market on dilution concerns, though the longer-term market verdict on whether this is $15 billion well spent will depend on the customer ramp Intel can demonstrate over the coming quarters.